Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis.
Cholangiocytes, the epithelial cells lining the biliary ducts, are the target cells in several liver diseases. Cholangiopathies and cholangiocarcinoma generate interest in many scientists since the genesis. The developing mechanisms, and the therapeutic tools of these diseases are still undefined. Several studies demonstrate that many hormones, neuropeptides and neurotransmitters regulate malignant and non-malignant cholangiocyte pathophysiology in the course of chronic biliary diseases. The aim of this review is to present the findings of several studies published in the recent years that contributed to clarifying the role of nervous and neuroendocrine regulation of the pathophysiologic events associated with cholestasis and cholangiocarcinoma development. This manuscript is organized into two parts. The first part offers an overview of the innervation of the liver and the origin of neuroendocrine hormones, neurotransmitters and neuropeptides affecting cholangiocyte function and metabolism. The first section also reviews the effects played by several neuroendocrine hormones and nervous system on cholangiocyte growth, survival and functional activity in the course of cholestasis. In the second section, we summarize the results of some studies describing the role of nervous system and neuroendocrine hormones in the regulation of malignant cholangiocyte growth.
Marzioni
Marco
M
Department of Gastroenterology, Università Politecnica delle Marche, Nuovo Polo Didattico, III piano, Via Tronto 10, 60020 Ancona, Italy. marco.marzioni@tele2.it
Fava
Giammarco
G
Benedetti
Antonio
A
D000818:Animals; D001650:Bile Duct Neoplasms / Q000503:physiopathology*; D001652:Bile Ducts / Q000473:pathology / Q000503:physiopathology; D049109:Cell Proliferation; D002779:Cholestasis / Q000503:physiopathology*; D006801:Humans; D008099:Liver / Q000294:innervation; D009420:Nervous System / Q000503:physiopathology*; D009478:Neuropeptide Y / Q000502:physiology; D009479:Neuropeptides / Q000502:physiology; D009490:Neurosecretory Systems / Q000503:physiopathology*; D018377:Neurotransmitter Agents / Q000502:physiology; D013004:Somatostatin / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D009478:Neuropeptide Y; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D013004:Somatostatin; D005680:gamma-Aminobutyric Acid